# Verrica Pharmaceuticals Inc. (VRCA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VRCA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 5.02M | $ -9.68M | $ -9.16M | $ 1.44M | $ 16.06M |
| 2025 | $ 36.43M | $ -18.31M | $ -18.05M | $ 1.63M | $ 24.74M |
| 2024 | $ 7.95M | $ -80.49M | $ -64.07M | $ 45.94M | $ -9.86M |
| 2023 | $ 5.54M | $ -72.44M | $ -42.10M | $ 45.51M | $ 19.76M |
| 2022 | $ 10.09M | $ -27.35M | $ -21.17M | $ 1.53M | $ 40.03M |
| 2021 | $ 14.26M | $ -41.70M | $ -33.83M | $ 43.41M | $ 32.61M |
| 2020 | $ 0 | $ -54.39M | $ -40.35M | $ 37.21M | $ 32.99M |
| 2019 | $ 0 | $ -36.41M | $ -36.26M | $ 188.0K | $ 65.02M |
| 2018 | $ 0 | $ -29.25M | $ -24.63M | $ 0 | $ 89.43M |
| 2017 | $ 0 | $ -6.01M | $ -6.17M | $ 0 | $ -7.04M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.09 |
| Liabilities / Eq | 1.42 |
| Current Ratio | 2.02 |

## Other views

- [Metrics](https://sponda.capital/en/VRCA.md)
- [Charts](https://sponda.capital/en/VRCA/charts.md)
- [Compare](https://sponda.capital/en/VRCA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.